Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.280
-0.070 (-5.19%)
Oct 8, 2025, 4:00 PM EDT - Market closed
Oncolytics Biotech Market Cap
Oncolytics Biotech has a market cap or net worth of $128.46 million as of October 8, 2025. Its market cap has increased by 83.36% in one year.
Market Cap
128.46M
Enterprise Value
118.39M
1-Year Change
83.36%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since October 5, 2001, Oncolytics Biotech's market cap has increased from $96.89M to $128.46M, an increase of 32.59%. That is a compound annual growth rate of 1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 128.46M | 82.40% |
| Dec 31, 2024 | 70.43M | -28.92% |
| Dec 29, 2023 | 99.09M | 2.98% |
| Dec 30, 2022 | 96.22M | 25.79% |
| Dec 31, 2021 | 76.49M | -25.81% |
| Dec 31, 2020 | 103.10M | -17.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |